17 Capital Partners’s Corteva CTVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$212K Sell
2,730
-27,185
-91% -$2.25M 0.22% 106
2026
Q2
$2.53M Buy
29,915
+24
+0.1% +$1.93K 1.14% 14
2026
Q1
$2.5M Sell
29,891
-2,261
-7% -$170K 1.29% 11
2025
Q4
$2.16M Sell
32,152
-637
-2% -$41.2K 1.11% 14
2025
Q3
$2.22M Buy
32,789
+40
+0.1% +$2.9K 1.21% 12
2025
Q2
$2.44M Sell
32,749
-1,757
-5% -$117K 1.41% 9
2025
Q1
$2.17M Buy
34,506
+125
+0.4% +$7.73K 1.39% 9
2024
Q4
$1.96M Hold
34,381
– – 1.24% 13
2024
Q3
$2.02M Hold
34,381
– – 1.32% 10
2024
Q2
$1.85M Sell
34,381
-273
-0.8% -$15K 1.32% 12
2024
Q1
$2M Buy
34,654
+250
+0.7% +$12.9K 1.48% 10
2023
Q4
$1.65M Buy
+34,404
New +$1.64M 1.51% 15
2022
Q3
$1.98M Sell
34,703
-24
-0.1% -$1.4K 2.72% 3
2022
Q2
$1.88M Sell
34,727
-406
-1% -$23.6K 2.37% 4
2022
Q1
$2.02M Hold
35,133
– – 2.11% 5
2021
Q4
$1.66M Sell
35,133
-2,138
-6% -$97.4K 1.51% 17
2021
Q3
$1.57M Hold
37,271
– – 1.48% 15
2021
Q2
$1.65M Buy
+37,271
New +$1.72M 1.54% 11

Other funds holding CTVA

17 Capital Partners's CTVA Position: Q3 2026 in Review

17 Capital Partners reduced its Corteva (CTVA) stake by 91% in Q3 2026, selling an estimated $2.25M and leaving 2,730 shares worth $212K. The position accounts for 0.22% of the portfolio, ranked #106.

17 Capital Partners first reported a position in CTVA in Q2 2021 and has held it in 18 quarters since. The position peaked at $2.53M in Q2 2026. 1,442 funds tracked by Wall St. Rank hold CTVA as of Q3 2026.

  • 17 Capital Partners held 2,730 shares of Corteva worth $212K as of Q3 2026.
  • 17 Capital Partners sold 27,185 Corteva shares in Q3 2026, an estimated $2.25M.
  • Corteva made up 0.22% of 17 Capital Partners's portfolio in Q3 2026, its #106 holding.
  • 17 Capital Partners first reported a position in Corteva in Q2 2021 and has held it in 18 quarters since.
  • 17 Capital Partners's Corteva position peaked at $2.53M in Q2 2026.
  • 1,442 funds tracked by Wall St. Rank held Corteva as of Q3 2026.

Based on 17 Capital Partners's 13F filing for Q3 2026, filed 16 Nov 2026.